|
WO2006086667A2
(en)
|
2005-02-09 |
2006-08-17 |
Avi Bio Pharma, Inc. |
Antisense composition and method for treating muscle atrophy
|
|
US8236557B2
(en)
*
|
2008-05-28 |
2012-08-07 |
University Of Missouri-Columbia |
Hybrid-AAV vectors to deliver large gene expression cassette
|
|
EP2396343B1
(en)
|
2009-02-11 |
2017-05-17 |
The University of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
US9169494B2
(en)
|
2010-01-12 |
2015-10-27 |
The University Of North Carolina At Chapel Hill |
Restrictive inverted terminal repeats for viral vectors
|
|
WO2011097456A2
(en)
|
2010-02-05 |
2011-08-11 |
The University Of North Carolina At Chapel Hill |
Compositions and methods for enhanced parvovirus transduction
|
|
CA2826273C
(en)
|
2011-02-10 |
2021-11-02 |
The University Of North Carolina At Chapel Hill |
Viral vectors with modified transduction profiles and methods of making and using the same
|
|
US20130085139A1
(en)
|
2011-10-04 |
2013-04-04 |
Royal Holloway And Bedford New College |
Oligomers
|
|
WO2013075008A1
(en)
*
|
2011-11-16 |
2013-05-23 |
University Of Florida Research Foundation Inc. |
Aav dual vector systems for gene therapy
|
|
CN103405774A
(zh)
*
|
2012-10-24 |
2013-11-27 |
尹海芳 |
一种新型药物靶向运输辅助剂
|
|
US20140140969A1
(en)
*
|
2012-11-20 |
2014-05-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for muscular dystrophies
|
|
US9624282B2
(en)
|
2012-11-26 |
2017-04-18 |
The Curators Of The University Of Missouri |
Microdystrophin peptides and methods for treating muscular dystrophy using the same
|
|
ES2926774T3
(es)
|
2013-03-15 |
2022-10-28 |
Univ North Carolina Chapel Hill |
Métodos y composiciones para vectores AAV de doble unión de glicano
|
|
EP2970966A4
(en)
|
2013-03-15 |
2016-10-26 |
Univ North Carolina |
SYNTHETIC ADENOASSOZED VIRUS INVERTED REPEAT SEQUENCES
|
|
AU2016206624B2
(en)
|
2015-01-14 |
2020-08-06 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for targeted gene transfer
|
|
WO2016115543A2
(en)
*
|
2015-01-16 |
2016-07-21 |
University Of Washington |
Novel micro-dystrophins and related methods of use
|
|
WO2016134300A1
(en)
|
2015-02-20 |
2016-08-25 |
Board Of Regents, The University Of Texas System |
Methods and compositions for attenuated chlamydia as vaccine and vector
|
|
GB201507842D0
(en)
*
|
2015-05-07 |
2015-06-17 |
New Royal Holloway & Bedford |
Production of large-sized microdystrophins in an AAV-based vector configuration
|
|
IL314171A
(en)
|
2015-09-28 |
2024-09-01 |
Univ Florida |
Methods and compositions for antibody-evading virus vectors
|
|
JP2018530560A
(ja)
|
2015-10-09 |
2018-10-18 |
サレプタ セラピューティクス， インコーポレイテッド |
デュシェンヌ型筋ジストロフィーおよび関連障害の処置のための組成物および方法
|
|
CN108463211B
(zh)
|
2015-11-16 |
2022-09-27 |
全国儿童医院研究所 |
用于治疗肌联蛋白类肌病和其它肌联蛋白病变的材料和方法
|
|
US11124546B2
(en)
|
2015-12-14 |
2021-09-21 |
The University Of North Carolina At Chapel Hill |
Modified capsid proteins for enhanced delivery of parvovirus vectors
|
|
WO2017181011A1
(en)
|
2016-04-15 |
2017-10-19 |
Research Institute At Nationwide Children's Hospital |
Adeno-associated virus vector delivery of microrna-29 to treat muscular dystrophy
|
|
CN109121395B
(zh)
|
2016-04-15 |
2022-08-09 |
全国儿童医院研究所 |
腺相关病毒载体递送β-肌聚糖和微RNA-29以及肌营养不良症的治疗
|
|
CA2971303C
(en)
*
|
2016-06-21 |
2026-03-03 |
Bamboo Therapeutics, Inc. |
Optimized mini-dystrophin genes and expression cassettes and their use
|
|
WO2017223128A1
(en)
*
|
2016-06-21 |
2017-12-28 |
The Curators Of The University Of Missouri |
Modified dystrophin proteins
|
|
JP6994018B2
(ja)
|
2016-07-26 |
2022-01-14 |
バイオマリン ファーマシューティカル インコーポレイテッド |
新規アデノ随伴ウイルスキャプシドタンパク質
|
|
ES2982489T3
(es)
|
2016-08-19 |
2024-10-16 |
Univ Florida |
Composiciones para el tratamiento de afecciones que utilizan virus adeno-asociados recombinantes autocomplementarios
|
|
US11958886B2
(en)
|
2016-12-07 |
2024-04-16 |
University Of Florida Research Foundation, Incorporated |
IL-1RA cDNAs
|
|
MA47820A
(fr)
|
2017-03-10 |
2020-01-15 |
Genethon |
Traitement de la glycogénose de type iii
|
|
WO2018170310A1
(en)
|
2017-03-15 |
2018-09-20 |
The University Of North Carolina At Chapel Hill |
Polyploid adeno-associated virus vectors and methods of making and using the same
|
|
US11338045B2
(en)
|
2017-03-17 |
2022-05-24 |
Newcastle University |
Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy
|
|
US12359221B2
(en)
|
2017-05-05 |
2025-07-15 |
The Regents Of The University Of California |
Compositions and methods for expressing otoferlin
|
|
WO2019078916A1
(en)
|
2017-10-18 |
2019-04-25 |
Research Institute At Nationwide Children's Hospital |
ADENO-ASSOCIATED VIRUS VECTOR ADMINISTRATION OF MUSCLE-SPECIFIC MICRO-DYSTROPHINE TO TREAT MUSCLE DYSTROPHY
|
|
KR102682430B1
(ko)
|
2017-11-22 |
2024-07-08 |
아지오스 파마슈티컬스 아이엔씨. |
N-(4-(4-(시클로프로필메틸)피페라진-1-카르보닐)페닐)퀴놀린-8-술폰아미드의 결정 형태
|
|
AU2019216257B2
(en)
|
2018-01-31 |
2025-11-20 |
Research Institute At Nationwide Children's Hospital |
Gene therapy for limb-girdle muscular dystrophy type 2C
|
|
CA3092107A1
(en)
|
2018-02-28 |
2019-09-06 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for antibody-evading virus vectors
|
|
BR112020020266A2
(pt)
|
2018-04-03 |
2021-01-19 |
Stridebio, Inc. |
Vetores de vírus com evasão de anticorpos
|
|
CA3095179A1
(en)
|
2018-04-03 |
2019-10-10 |
Stridebio, Inc. |
Antibody-evading virus vectors
|
|
MX2020010465A
(es)
|
2018-04-03 |
2021-01-08 |
|
Vectores de virus para direccionamiento a tejidos oftalmicos.
|
|
CA3099958A1
(en)
|
2018-04-16 |
2019-10-24 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treating duchenne muscular dystrophy
|
|
CN112703016B
(zh)
|
2018-04-27 |
2024-11-22 |
分贝治疗公司 |
肌球蛋白15启动子及其用途
|
|
US11660353B2
(en)
|
2018-04-27 |
2023-05-30 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
KR20210008501A
(ko)
|
2018-05-09 |
2021-01-22 |
바이오마린 파머수티컬 인크. |
페닐케톤뇨증을 치료하는 방법
|
|
TW202005978A
(zh)
|
2018-05-14 |
2020-02-01 |
美商拜奧馬林製藥公司 |
新穎肝靶向腺相關病毒載體
|
|
US10765760B2
(en)
|
2018-05-29 |
2020-09-08 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomer conjugates for muscular dystrophy
|
|
IL324506A
(en)
*
|
2018-06-18 |
2026-01-01 |
Res Inst Nationwide Childrens Hospital |
Adeno-associated virus vector for delivery of muscle-specific microdystrophin for the treatment of muscular dystrophy
|
|
CN112639110A
(zh)
|
2018-06-22 |
2021-04-09 |
阿斯克肋匹奥生物制药公司 |
用于基因递送以在细胞内持续存在的载体
|
|
IL279789B2
(en)
|
2018-06-29 |
2026-04-01 |
Res Inst Nationwide Childrens Hospital |
Recombinant adeno-associated virus products and methods for treating limb girdle muscular dystrophy 2A
|
|
CN113613668A
(zh)
|
2018-10-24 |
2021-11-05 |
百时美施贵宝公司 |
小型化肌营养不良蛋白及其用途
|
|
WO2020093018A1
(en)
|
2018-11-01 |
2020-05-07 |
University Of Florida Research Foundation, Incorporated |
A codon optimized otoferlin aav dual vector gene therapy
|
|
WO2020163761A1
(en)
|
2019-02-08 |
2020-08-13 |
Decibel Therapeutics, Inc. |
Myosin 15 promoters and uses thereof
|
|
EP3921032A4
(en)
|
2019-02-08 |
2022-11-30 |
Decibel Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
|
|
KR20210133242A
(ko)
|
2019-02-26 |
2021-11-05 |
더 리서치 인스티튜트 앳 네이션와이드 칠드런스 하스피탈 |
B-사르코글리칸의 아데노 관련 바이러스 벡터 전달 및 근이영양증의 치료
|
|
CN113727992A
(zh)
|
2019-03-21 |
2021-11-30 |
斯特里迪比奥公司 |
重组腺相关病毒载体
|
|
EP3947427A1
(en)
*
|
2019-03-25 |
2022-02-09 |
Genethon |
Production of large-sized quasidystrophins using overlapping aav vectors
|
|
AU2020263392A1
(en)
|
2019-04-26 |
2021-10-28 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for dual glycan binding AAV2.5 vector
|
|
EP3976806A1
(en)
|
2019-05-30 |
2022-04-06 |
Solidus Biosciences, Inc. |
Recombinant herpesvirales vector
|
|
EP3997109A4
(en)
*
|
2019-07-10 |
2023-11-01 |
University of Washington |
Non-viral immuno-targeting
|
|
CA3150964A1
(en)
|
2019-08-21 |
2021-02-25 |
Research Institute At Nationwide Children's Hospital |
Adeno-associated virus vector delivery of alpha-sarcoglycan and the treatment of muscular dystrophy
|
|
IL291944A
(en)
|
2019-10-10 |
2022-06-01 |
Solid Biosciences Inc |
Modified aav capsids and uses thereof
|
|
MX2022004353A
(es)
|
2019-10-17 |
2022-07-19 |
|
Casete de transferencia de aav.
|
|
CN114787180A
(zh)
|
2019-10-17 |
2022-07-22 |
斯特里迪比奥公司 |
用于治疗c型尼曼-匹克病的腺相关病毒载体
|
|
TWI896570B
(zh)
|
2019-10-30 |
2025-09-11 |
美商迪賽博治療公司 |
使用耳畸蛋白雙載體系統治療感覺神經性聽力損失之組合物及方法
|
|
WO2021089736A1
(en)
|
2019-11-06 |
2021-05-14 |
Association Institut De Myologie |
Combined therapy for muscular diseases
|
|
AU2020392243A1
(en)
*
|
2019-11-28 |
2022-06-16 |
Regenxbio Inc. |
Microdystrophin gene therapy constructs and uses thereof
|
|
IL295741A
(en)
|
2020-04-01 |
2022-10-01 |
Univ Florida |
Dual aav-myo7a vectors with improved safety for the treatment of ush1b
|
|
US11535868B2
(en)
*
|
2020-04-29 |
2022-12-27 |
Bristol-Myers Squibb Company |
Miniaturized dystrophins having spectrin fusion domains and uses thereof
|
|
JP2023542614A
(ja)
|
2020-08-19 |
2023-10-11 |
サレプタ セラピューティクス， インコーポレイテッド |
レット症候群の治療のためのアデノ随伴ウイルスベクター
|
|
WO2022076750A2
(en)
|
2020-10-07 |
2022-04-14 |
Regenxbio Inc. |
Recombinant adeno-associated viruses for cns or muscle delivery
|
|
CN116490514A
(zh)
|
2020-10-28 |
2023-07-25 |
北卡罗来纳-查佩尔山大学 |
用于双重聚糖结合aav2.5载体的方法和组合物
|
|
TW202242124A
(zh)
|
2021-01-14 |
2022-11-01 |
美商史崔德生物公司 |
靶向ｔ細胞之ａａｖ載體
|
|
CA3218333A1
(en)
|
2021-04-05 |
2022-10-13 |
Solid Biosciences Inc. |
Recombinant herpesvirales vector
|
|
JP2024515626A
(ja)
|
2021-04-16 |
2024-04-10 |
アスクレピオス バイオファーマシューティカル， インコーポレイテッド |
血液脳関門を横断し低減された液性応答を惹起する合理的ポリプロイドａａｖビリオン
|
|
IL307902A
(en)
*
|
2021-04-26 |
2023-12-01 |
Regenxbio Inc |
Microdystrophin gene therapy administration for treatment of dystrophinopathies
|
|
US20240390522A1
(en)
*
|
2021-09-28 |
2024-11-28 |
University Of Florida Research Foundation, Incorporated |
Gene therapy for duchenne muscular dystrophy
|
|
EP4413018A1
(en)
|
2021-10-07 |
2024-08-14 |
RegenxBio Inc. |
Recombinant adeno-associated viruses for targeted delivery
|
|
CN115960946B
(zh)
*
|
2021-10-09 |
2026-02-13 |
中国科学院分子植物科学卓越创新中心 |
调节植物镁离子吸收和转运的方法
|
|
US12285497B2
(en)
|
2021-10-15 |
2025-04-29 |
Research Institute At Nationwide Children's Hospital |
Self-complementary adeno-associated virus vector and its use in treatment of muscular dystrophy
|
|
CA3248878A1
(en)
*
|
2022-01-17 |
2023-07-20 |
Dinaqor Ag |
GENE THERAPY COMPOSITION AND TREATMENT OF DYSTROPHIN-RELATED CARDIOMYOPATHY
|
|
EP4215614A1
(en)
|
2022-01-24 |
2023-07-26 |
Dynacure |
Combination therapy for dystrophin-related diseases
|
|
TW202342759A
(zh)
|
2022-02-04 |
2023-11-01 |
美商史崔德生物公司 |
重組腺相關病毒載體及其使用方法
|
|
US20250288641A1
(en)
*
|
2022-04-27 |
2025-09-18 |
The Curators Of The University Of Missouri |
Micro-dystrophin for heart protection
|
|
WO2024124019A2
(en)
|
2022-12-07 |
2024-06-13 |
Ginkgo Bioworks, Inc. |
Aav vectors targeting hematopoietic stem cells
|
|
EP4694904A2
(en)
|
2023-04-13 |
2026-02-18 |
REGENXBIO Inc. |
Targeting aav capsids, methods of manufacturing and using same
|
|
WO2025017168A1
(en)
*
|
2023-07-19 |
2025-01-23 |
Genethon |
Novel optimized utrophin micro-genes
|
|
WO2026094009A1
(en)
*
|
2024-11-04 |
2026-05-07 |
Insmed Incorporated |
Compositions and methods for treating duchenne muscular dystrophy
|